Walgreens Stock Falls Over 3% In Premarket As Wall Street Veterans Debate Private Equity Deal Value Amid Sycamore Takeover Talks
Walgreens Stock Falls Over 3% In Premarket As Wall Street Veterans Debate Private Equity Deal Value Amid Sycamore Takeover Talks
$WBA +20% to $10.70 on reports that private equity firm Sycamore Partners is in talks to take Walgreens private. My back-of-the-envelope math suggests a $15/share ($13B total) bid could be on the table, which assumes a paltry 6x EV/EBITDA deal price (equates to 16.6% pretax cash...Walgreens Boots Alliance Inc. (NASDAQ:WBA) retreated 3.26% to $10.08 in Wednesday's pre-market trading, following Tuesday's 20% surge, as prominent market voices weighed in on the potential private takeover by Sycamore Partners.
沃爾格林聯合公司（納斯達克：WBA）在週三的美股盤前交易中下跌3.26%，至10.08美元，此前在週二上漲了20%，因爲市場上的重要聲音對Sycamore Partners可能的私有化收購發表了看法。
What Happened: Gary Black, Managing Partner at The Future Fund LLC, outlined a detailed valuation case for a possible $15 per share offer.
發生了什麼：The Future Fund LLC的管理合夥人加里·布萊克爲可能的每股15美元的報價概述了詳細的估值案例。
Walgreens management guided for the fiscal year 2025, expecting adjusted earnings per share to range between $1.40 and $1.80 during their most recent earnings call. At the current stock price of $10.70, this places WBA's price-to-earnings ratio at 6.7 times the fiscal year 2025 EPS, Black wrote on X, noting that the stock currently offers a 9.3% dividend yield.
沃爾格林管理層預計2025財年的調整後每股收益將在最近的業績會上指導爲1.40美元到1.80美元區間。在當前股價10.70美元的情況下，這使得WBA的市盈率爲2025財年每股收益的6.7倍，布萊克在X上寫道，並指出該股票目前提供9.3%的股息收益率。
$WBA +20% to $10.70 on reports that private equity firm Sycamore Partners is in talks to take Walgreens private. My back-of-the-envelope math suggests a $15/share ($13B total) bid could be on the table, which assumes a paltry 6x EV/EBITDA deal price (equates to 16.6% pretax cash...
— Gary Black (@garyblack00) December 10, 2024
$WBA在有報道稱股權投資公司Sycamore Partners正在與沃爾格林進行私有化談判後上漲20%至10.70美元。我的粗略計算顯示，可能會提出每股15美元（總計130億）的買盤，這假設了一個微薄的6倍企業價值/稅息折舊及攤銷前利潤的交易價格（相當於16.6%的稅前現金...
— Gary Black (@garyblack00) 2024年12月10日
CNBC's Jim Cramer struck a more cautious tone, warning investors about the deal's complexity. "Wow, Walgreen's too tough to turn even for the great Wentworth whom I revere. Don't overpay for this one..." Cramer posted on X.
CNBC的吉姆·克萊默採取了更爲謹慎的語氣，警告投資者關於此交易的複雜性。"哇，沃爾格林太難以收購了，即便是我崇敬的偉大溫特沃斯。不要爲這個價格支付過高..."克萊默在X上發佈了這一消息。
Wow, Walgreen's too tough to turn even for the great Wentworth whom i revere. Don't overpay for this one...
— Jim Cramer (@jimcramer) December 10, 2024
哇，沃爾格林太難以收購了，即便是我崇敬的偉大溫特沃斯。不要爲這個價格支付過高...
— 吉姆·克萊默 (@jimcramer) 2024年12月10日
What Happened: The commentary comes amid Walgreens' stark decline from its December 2015 peak of $85 per share, when it commanded a $100 billion market value. The pharmacy chain, now valued at roughly $9 billion, has lost 82% of its value since 2020 as it faces growing competition from online pharmacies and Amazon.com Inc.
事件背景：這一評論是在沃爾格林從2015年12月每股85美元的高峰期急劇下滑的背景下發布的，當時其市值達到1000億美元。現在該藥房連鎖的估值約爲90億，自2020年以來，其價值已下降了82%，面臨來自在線藥房和亞馬遜公司的日益競爭。
The Wall Street Journal reported that Sycamore Partners, which previously acquired Staples for $7 billion in 2017, might seek partners or divest certain assets if a deal materializes. This approach differs from KKR's failed 2019 bid of approximately $70 billion, which Walgreens' board rejected as insufficient.
《華爾街日報》報道稱，曾在2017年以70億收購Staples的Sycamore Partners，可能會尋求合作伙伴或剝離某些資產，以便如果交易成行。這種方法與KKR在2019年提出的大約700億的買盤不同，後者被沃爾格林董事會拒絕，認爲金額不夠。
Walgreens' recent struggles are evident in its latest quarterly results, where adjusted earnings dropped 41% despite revenue growth, leading to plans for closing 1,200 stores over three years.
沃爾格林最近的困境在其最新的季度業績中顯而易見，儘管營業收入有所增長，調整後的每股收益卻下降了41%，導致計劃在三年內關閉1200家門店。
- Robotaxi Exit To 'Clear The Way' For GM To License Tesla FSD, Says Gary Black — Move Will Save The Mary Barra-Led Company $1B A Year
- Robotaxi退出將 "清理道路" 以便通用汽車獲得特斯拉的FSD許可，Gary Black表示——此舉將爲瑪麗·巴拉領導的公司每年節省10億美元
Image via Unsplash
圖片來自Unsplash
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
免責聲明：本內容部分使用人工智能工具生成，並經Benzinga編輯審核發佈。
譯文內容由第三人軟體翻譯。
